Method for producing native HIV gp160
US5116740A · kind A · utility
6Cited by
0References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 7, 1989 |
| Grant date | May 26, 1992 |
| Priority date | — |
| Expiry date | Jun 7, 2009 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/974
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Human Immunodeficiency Virus (HIV) glycoprotein gp160 is produced in its native form using a clone of HUT78 cells chronically infected with HTLV-III.sub.451, and grown in serum-free medium.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.